DiaMedica Therapeutics (DMAC) EPS (Basic): 2018-2019
Historic EPS (Basic) for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to -$0.21.
- DiaMedica Therapeutics' EPS (Basic) rose 8.70% to -$0.21 in Q4 2019 from the same period last year, while for Dec 2019 it was -$0.89, marking a year-over-year decrease of 21.92%. This contributed to the annual value of -$0.60 for FY2024, which is negligibly% changed negligibly from last year.
- DiaMedica Therapeutics' EPS (Basic) amounted to -$0.21 in Q4 2019, which was down 5.00% from -$0.20 recorded in Q3 2019.
- In the past 5 years, DiaMedica Therapeutics' EPS (Basic) ranged from a high of -$0.10 in Q1 2018 and a low of -$0.27 during Q1 2019.
- For the 2-year period, DiaMedica Therapeutics' EPS (Basic) averaged around -$0.20, with its median value being -$0.21 (2019).
- The largest annual percentage gain for DiaMedica Therapeutics' EPS (Basic) in the last 5 years was 8.70% (2019), contrasted with its biggest fall of 170.00% (2019).
- Over the past 2 years, DiaMedica Therapeutics' EPS (Basic) (Quarterly) stood at -$0.23 in 2018, then grew by 8.70% to -$0.21 in 2019.
- Its EPS (Basic) was -$0.21 in Q4 2019, compared to -$0.20 in Q3 2019 and -$0.21 in Q2 2019.